Germany· DE-A57-65f9c6cfbb9e840e

Capval-Tropfen

A noscapine product containing noscapine, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim. The same ATC class is registered in 8 of our 19 countries.

ATC R05DA07

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCapval-TropfenATCR05DA07REGISTER NO.DE-A57-65f9c6cfbb9e84…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Noscapine is registered in 8 of 19 countries.

Countries holding a registration under ATC R05DA07 (noscapine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 4 of them publish a price we can compare per daily dose

Noscapine · ATC R05DA07

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Noscapine
Manufacturer
Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
Country
Germany (DE)
ATC code
R05DA07
ATC class
Noscapine
Defined daily dose
0.125 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Noscapine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All noscapine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Belgium · Nosca-Méréprine
  • Denmark · Noskapin Dak
  • Spain · Tuscalman, Tuscalman Ninos
  • Luxembourg · Nosca Méréprine, Nosca-Méréprine
  • Netherlands · Hoestdrank Noscapine Hcl Etos, Hoestdrank Noscapine Hcl Htp
  • Norway · Noskapin Orifarm Healthcare
  • Sweden · Nipaxon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/68074209-b8ad-434c-9a33-58714a8e4284
GET /v1/drugs/68074209-b8ad-434c-9a33-58714a8e4284?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Noscapine",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about noscapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.